Partial depletion of dopamine in substantia nigra impairs motor performance without altering striatal dopamine neurotransmission

European Journal of Neuroscience

Volumn 24, Issue 2, 2006, Pages 617-624

  Andersson, Daniel R ^a   Nissbrandt, Hans ^a   Bergquist, Filip ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Microdialysis; Rat; Rotarod; Tetrabenazine

Indexed keywords

DOPAMINE; TETRABENAZINE; VESICULAR MONOAMINE TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DIALYSATE; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; FEMALE; MICRODIALYSIS; MOTOR ACTIVITY; MOTOR COORDINATION; MOTOR PERFORMANCE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; ROTAROD TEST; STATISTICAL SIGNIFICANCE; SUBSTANTIA NIGRA;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; CORPUS STRIATUM; DENDRITES; DISEASE MODELS, ANIMAL; DOPAMINE; EXTRACELLULAR FLUID; FEMALE; MOTOR ACTIVITY; MOVEMENT; MOVEMENT DISORDERS; NEURAL PATHWAYS; PARKINSONIAN DISORDERS; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION; TETRABENAZINE; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 33746215742     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2006.04953.x     Document Type: Article

References (59)

1. Adachi, Y.U., Satomoto, M., Higuchi, H., Watanabe, K., Yamada, S. & Kazama, T. (2005) Halothane enhances dopamine metabolism at presynaptic sites in a calcium-independent manner in rat striatum. Br. J. Anaesth., 95, 485-494.
2. Aghajanian, G. & Bunney, B. (1973) Central dopaminergic neurons: neurophysiological identification and responses to drugs. In Usdin, E. & Snyder, S. (eds), Frontiers in Catecholamine Research. Pergamon Press, New York, pp. 643-648.
3. Bata-Garcia, J.L., Heredia-Lopez, F.J., Alvarez-Cervera, F.J., Arankowsky-Sandoval, G. & Gongora-Alfaro, J.L. (2002) Circling behavior induced by microinjection of serotonin reuptake inhibitors in the substantia nigra. Pharmacol. Biochem. Behav., 71, 353-363.
4. Beckstead, M.J., Grandy, D.K., Wickman, K. & Williams, J.T. (2004) Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons. Neuron, 42, 939-946.
5. Bergquist, F., Jonason, J., Pileblad, E. & Nissbrandt, H. (1998) Effects of local administration of L-, N-, and P/Q-type calcium channel blockers on spontaneous dopamine release in the striatum and the substantia nigra: a microdialysis study in rat. J. Neurochem., 70, 1532-1540.
6. Bergquist, F., Shahabi, H.N. & Nissbrandt, H. (2003) Somatodendritic dopamine release in rat substantia nigra influences motor performance on the accelerating rod. Brain Res., 973, 81-91.
7. Bernardini, G.L., Gu, X., Viscardi, E. & German, D.C. (1991) Amphetamine-induced and spontaneous release of dopamine from A9 and A10 cell dendrites: an in vitro electrophysiological study in the mouse. J. Neural Transm. General Sect., 84, 183-193.
8. Bjorklund, A. & Lindvall, O. (1975) Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals. Brain Res., 83, 531-537.
9. Bustos, G., Abarca, J., Campusano, J., Bustos, V., Noriega, V. & Aliaga, E. (2004) Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain. Brain Res. Brain Res. Rev., 47, 126-144.
10. Carlsson, A. & Lindqvist, M. (1978) Effects of antidepressant agents on the synthesis of brain monoamines. J. Neural Transm., 43, 73-91.
11. Celada, P., Paladini, C.A. & Tepper, J.M. (1999) Gabaergic control of rat substantia nigra dopaminergic neurons: Role of globus pallidus and substantia nigra pars reticulata. Neuroscience, 89, 813-825.
12. Cobb, W.S. & Abercrombie, E.D. (2002) Distinct roles for nigral GABA and glutamate receptors in the regulation of dendritic dopamine release under normal conditions and in response to systemic haloperidol. J. Neurosci., 22, 1407-1413.
13. Cobb, W.S. & Abercrombie, E.D. (2003a) Differential regulation of somatodendritic and nerve terminal dopamine release by serotonergic innervation of substantia nigra. J. Neurochem., 84, 576-584.
14. Cobb, W.S. & Abercrombie, E.D. (2003b) Relative involvement of globus pallidus and subthalamic nucleus in the regulation of somatodendritic dopamine release in substantia nigra is dopamine-dependent. Neuroscience, 119, 777-786.
15. Collier, T.J., Sortwell, C.E., Elsworth, J.D., Taylor, J.R., Roth, R.H., Sladek, J.R. Jr & Redmond, D.E. Jr (2002) Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease. J. Comp. Neurol., 442, 320-330.
16. Cragg, S.J. & Greenfield, S.A. (1997) Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum. J. Neurosci., 17, 5738-5746.
17. Cremades, A., Serrano, J.S., Jane, F. & Milanes, M.V. (1982) Effect of reserpine on body temperature in the rat after pretreatment with amphetamine and monoamineoxidase inhibitors. Meth. Find. Exp. Clin. Pharmacol., 4, 563-568.
18. Crocker, A.D. (1997) The regulation of motor control: an evaluation of the role of dopamine receptors in the substantia nigra. Rev. Neurosci., 8, 55-76.
19. DeLong, M.R. (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci., 13, 281-285.
20. Elverfors, A., Jonason, J., Jonason, G., Leonsson, G. & Nissbrandt, H. (1992) Determination of release of endogenous dopamine from superfused substantia nigra slices. J. Neurosci. Meth., 45, 209-215.
21. Elverfors, A. & Nissbrandt, H. (1991) Reserpine-insensitive dopamine release in the substantia nigra? Brain Res., 557, 5-12.
22. Elverfors, A., Pileblad, E., Lagerkvist, S., Bergquist, F., Jonason, J. & Nissbrandt, H. (1997) 3-Methoxytyramine formation following monoamine oxidase inhibition is a poor index of dendritic dopamine release in the substantia nigra. J. Neurochem., 69, 1684-1692.
23. Engberg, G., Elverfors, A., Jonason, J. & Nissbrandt, H. (1997) Inhibition of dopamine re uptake: significance for nigral dopamine neuron activity. Synapse, 25, 215-226.
24. Falkenburger, B.H., Barstow, K.L. & Mintz, I.M. (2001) Dendrodendritic inhibition through reversal of dopamine transport. Science, 293, 2465-2470.
25. Floran, B., Aceves, J., Sierra, A. & Martinez-Fong, D. (1990) Activation of D1 dopamine receptors stimulates the release of GABA in the basal ganglia of the rat. Neurosci. Lett., 116, 136-140.
26. Geffen, L.B., Jessell, T.M., Cuello, A.C. & Iversen, L.L. (1976) Release of dopamine from dendrites in rat substantia nigra. Nature, 260, 258-260.
27. Groves, P.M., Wilson, C.J., Young, S.J. & Rebec, G.V. (1975) Self-inhibition by dopaminergic neurons. Science, 190, 522-528.
28. Hattori, T., McGeer, P.L. & McGeer, E.G. (1979) Dendro axonic neurotransmission. II. Morphological sites for the synthesis, binding and release of neurotransmitters in dopaminergic dendrites in the substantia nigra and cholinergic dendrites in the neostriatum. Brain Res., 170, 71-83.
29. Heeringa, M.J. & Abercrombie, E.D. (1995) Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release. J. Neurochem., 65, 192-200.
30. Hong, M., Jenner, P. & Marsden, C.D. (1987) Comparison of the acute actions of amine-depleting drugs and dopamine receptor antagonists on dopamine function in the brain in rats. Neuropharmacology, 26, 237-245.
31. Hunt, P. & Oberlander, C. (1981) The interaction of indole derivatives with the serotonin receptor and non-dopaminergic circling behaviour. Adv. Exp. Med. Biol., 133, 547-562.
32. Ibanez-Sandoval, O., Hernandez, A., Floran, B., Galarraga, E., Tapia, D., Valdiosera, R., Erlij, D., Aceves, J. & Bargas, J. (2006) Control of the subthalamic innervation of substantia nigra pars reticulata by D1 and D2 dopamine receptors. J. Neurophysiol., 95, 1800-1811.
33. Imperato, A. & Di Chiara, G. (1984) Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites. J. Neurosci., 4, 966-977.
34. Login, I.S., Cronin, M.J., Harcus, C.T. & MacLeod, R.M. (1983) Neuroendocrine evidence that tetrabenazine is a dopamine antagonist. Proc. Soc. Exp. Biol. Med., 172, 225-231.
35. Martin, L.P. & Waszczak, B.L. (1994) D1 agonist-induced excitation of substantia nigra pars reticulata neurons: mediation by D1 receptors on striatonigral terminals via a pertussis toxin-sensitive coupling pathway. J. Neurosci., 14, 4494-4506.
36. Martin, L.P. & Waszczak, B.L. (1996) Dopamine D2, receptor-mediated modulation of the GABAergic inhibition of substantia nigra pars reticulata neurons. Brain Res., 729, 156-169.
37. Matuszewich, L. & Yamamoto, B.K. (1999) Modulation of GABA release by dopamine in the substantia nigra. Synapse, 32, 29-36.
38. Miyazaki, T. & Lacey, M.G. (1998) Presynaptic inhibition by dopamine of a discrete component of GABA release in rat substantia nigra pars reticulate. J. Physiol. (Lond.), 513, 805-817.
39. Nedergaard, S., Bolam, J.P. & Greenfield, S.A. (1988) Facilitation of a dendritic calcium conductance by 5-hydroxytryptamine in the substantia nigra. Nature, 333, 174-177.
40. Nikkhah, G., Bentlage, C., Cunningham, M.G. & Bjorklund, A. (1994) Intranigral fetal dopamine grafts induce behavioral compensation in the rat Parkinson model. J. Neurosci., 14, 3449-3461.
41. Nirenberg, M.J., Chan, J., Liu, Y., Edwards, R.H. & Pickel, V.M. (1996) Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine. J. Neurosci., 16, 4135-4145.
42. Oberlander, C., Hunt, P.F., Dumont, C. & Boissier, J.R. (1981) Dopamine independent rotational response to unilateral intranigral injection of serotonin. Life Sci., 28, 2595-2601.
43. Paladini, C.A., Celada, P. & Tepper, J.M. (1999) Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA (A) receptors in vivo. Neuroscience, 89, 799-812.
44. Radnikow, G. & Misgeld, U. (1998) Dopamine D1 receptors facilitate GABAA synaptic currents in the rat substantia nigra pars reticulata. J. Neurosci., 18, 2009-2016.
45. Reches, A., Burke, R.E., Kuhn, C.M., Hassan, M.N., Jackson, V.R. & Fahn, S. (1983) Tetrabenazine, an amine-depleting drug, also blocks dopamine receptors in rat brain. J. Pharmacol. Exp. Ther., 225, 515-521.
46. Rosales, M.G., Flores, G., Hernandez, S., Martinez-Fong, D. & Aceves, J. (1994) Activation of subthalamic neurons produces NMDA receptor-mediated dendritic dopamine release in substantia nigra pars reticulata: a microdialysis study in the rat. Brain Res., 645, 335-337.
47. Rosales, M.G., Martinez-Fong, D., Morales, R., Nunez, A., Flores, G., Gongora-Alfaro, J.L., Floran, B. & Aceves, J. (1997) Reciprocal interaction between glutamate and dopamine in the pars reticulata of the rat substantia nigra: a microdialysis study. Neuroscience, 80, 803-810.
48. Santiago, M. & Westerink, B.H. (1991) The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors. Eur. J. Pharmacol., 204, 79-85.
49. Silva, N.L. & Bunney, B.S. (1988) Intracellular studies of dopamine neurons in vitro: pacemakers modulated by dopamine. Eur. J. Pharmacol., 149, 307-315.
50. Smith, Y. & Bolam, J.P. (1990) The output neurones and the dopaminergic neurones of the substantia nigra receive a GABA-containing input from the globus pallidus in the rat. J. Comp. Neurol., 296, 47-64.
51. Smith, Y., Shink, E. & Sidibe, M. (1998) Neuronal circuitry and synaptic connectivity of the basal ganglia. Neurosurg. Clin. N. Am., 9, 203-222.
52. Tepper, J.M., Martin, L.P. & Anderson, D.R. (1995) GABAA receptor-mediated inhibition of rat substantia nigra dopaminergic neurons by pars reticulata projection neurons. J. Neurosci., 15, 3092-3103.
53. Tepper, J.M., Sun, B.C., Martin, L.P. & Creese, I. (1997) Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo. J. Neurosci., 17, 2519-2530.
54. Thorre, K., Ebinger, G. & Michotte, Y. (1998) 5-HT4 receptor involvement in the serotonin-enhanced dopamine efflux from the substantia nigra of the freely moving rat: a microdialysis study. Brain Res., 796, 117-124.
55. Timmerman, W. & Abercrombie, E.D. (1996) Amphetamine-induced release of dendritic dopamine in substantia nigra pars reticulata: D1-mediated behavioral and electrophysiological effects. Synapse, 23, 280-291.
56. Williams, J. & Davies, J.A. (1983) The involvement of 5-hydroxytryptamine in the release of dendritic dopamine from slices of rat substantia nigra. J. Pharm. Pharmacol., 35, 734-737.
57. Wilson, C.J., Groves, P.M. & Fifkova, E. (1977) Monoaminergic synapses, including dendro-dendritic synapses in the rat substantia nigra. Exp. Brain Res., 30, 161-174.
58. Yurek, D.M. (1997) Intranigral transplants of fetal ventral mesencephalic tissue attenuate D1-agonist-induced rotational behavior. Exp. Neurol., 143, 1-9.
59. Yurek, D.M. & Hipkens, S.B. (1993) Intranigral injections of SCH 23390 inhibit amphetamine-induced rotational behavior. Brain Res., 623, 56-64.